{
    "title": "France's Ose to enrol up to 400 for 'T-cell' coronavirus vaccine trials",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8856361/Frances-Ose-enrol-400-T-cell-coronavirus-vaccine-trials.html",
    "date": "2020-10-19",
    "keywords": [
        "vaccine",
        "virus",
        "coronavirus",
        "year",
        "approach",
        "company",
        "oct",
        "weapon",
        "battle",
        "executive",
        "alexis",
        "europe",
        "modus",
        "operandi",
        "meant",
        "role",
        "research",
        "effect",
        "oncology",
        "autoimmune",
        "subgroup",
        "killer",
        "infantry",
        "combination",
        "cancer",
        "protection",
        "product",
        "tcell",
        "world",
        "health",
        "handful",
        "valneva",
        "osivax",
        "pasteur",
        "end",
        "safety",
        "response",
        "plan",
        "partner",
        "industry",
        "phase",
        "iii",
        "september",
        "merck",
        "amp",
        "co",
        "astrazeneca",
        "stage",
        "production",
        "availability",
        "supply",
        "space",
        "blamont",
        "reporting",
        "burger",
        "frankfurt",
        "editing",
        "mark",
        "potter"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}